Cargando…
Clinical pharmacy in Israel versus the US, can we "compare apples to apples"?—commentary
Clinical pharmacy is an umbrella of pharmaceutical services that is practiced by clinical pharmacists. Clinical pharmacists improve the quality of drug therapy, minimize the risk for drug related problems, reduce the risk of morbidity and mortality associated with polypharmacy and decrease the overa...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670070/ https://www.ncbi.nlm.nih.gov/pubmed/34903284 http://dx.doi.org/10.1186/s13584-021-00508-3 |
_version_ | 1784614904515264512 |
---|---|
author | Schwartzberg, Eyal Marom, Eli |
author_facet | Schwartzberg, Eyal Marom, Eli |
author_sort | Schwartzberg, Eyal |
collection | PubMed |
description | Clinical pharmacy is an umbrella of pharmaceutical services that is practiced by clinical pharmacists. Clinical pharmacists improve the quality of drug therapy, minimize the risk for drug related problems, reduce the risk of morbidity and mortality associated with polypharmacy and decrease the overall healthcare expenditure. Consequently, clinical pharmacy is focused on both the needs of the individual patient, as well as of the healthcare system. Clinical pharmacy is now well-established and practiced worldwide and in the last two decades has been implemented successfully in Israel. This commentary maintains that the comparison of clinical pharmacy practice in Israel and in the United States, published by AJ Rose et al., has several limitations that need to be considered when devising a road map that will fit the Israeli health care system and its environment. Emphasis should be placed on the implementation of automation and robotics, promulgating regulations to allow for integration of pharmacy technicians, and allocating funds for such services. |
format | Online Article Text |
id | pubmed-8670070 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86700702021-12-15 Clinical pharmacy in Israel versus the US, can we "compare apples to apples"?—commentary Schwartzberg, Eyal Marom, Eli Isr J Health Policy Res Commentary Clinical pharmacy is an umbrella of pharmaceutical services that is practiced by clinical pharmacists. Clinical pharmacists improve the quality of drug therapy, minimize the risk for drug related problems, reduce the risk of morbidity and mortality associated with polypharmacy and decrease the overall healthcare expenditure. Consequently, clinical pharmacy is focused on both the needs of the individual patient, as well as of the healthcare system. Clinical pharmacy is now well-established and practiced worldwide and in the last two decades has been implemented successfully in Israel. This commentary maintains that the comparison of clinical pharmacy practice in Israel and in the United States, published by AJ Rose et al., has several limitations that need to be considered when devising a road map that will fit the Israeli health care system and its environment. Emphasis should be placed on the implementation of automation and robotics, promulgating regulations to allow for integration of pharmacy technicians, and allocating funds for such services. BioMed Central 2021-12-13 /pmc/articles/PMC8670070/ /pubmed/34903284 http://dx.doi.org/10.1186/s13584-021-00508-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Commentary Schwartzberg, Eyal Marom, Eli Clinical pharmacy in Israel versus the US, can we "compare apples to apples"?—commentary |
title | Clinical pharmacy in Israel versus the US, can we "compare apples to apples"?—commentary |
title_full | Clinical pharmacy in Israel versus the US, can we "compare apples to apples"?—commentary |
title_fullStr | Clinical pharmacy in Israel versus the US, can we "compare apples to apples"?—commentary |
title_full_unstemmed | Clinical pharmacy in Israel versus the US, can we "compare apples to apples"?—commentary |
title_short | Clinical pharmacy in Israel versus the US, can we "compare apples to apples"?—commentary |
title_sort | clinical pharmacy in israel versus the us, can we "compare apples to apples"?—commentary |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670070/ https://www.ncbi.nlm.nih.gov/pubmed/34903284 http://dx.doi.org/10.1186/s13584-021-00508-3 |
work_keys_str_mv | AT schwartzbergeyal clinicalpharmacyinisraelversustheuscanwecompareapplestoapplescommentary AT maromeli clinicalpharmacyinisraelversustheuscanwecompareapplestoapplescommentary |